TABLE 4

Five-year Survival Probabilities (and 95% CI) by 4-Year Time Period of Diagnosis for Children Aged 0 to 14 Years Diagnosed With an Embryonal Tumor in Germany, 1991–2010

ICCC-33 Diagnostic Subgroup5-Year Survival Probability
1991–19941995–19981999–20022003–20062007–2010
Na% (95% CI)Na% (95% CI)Na% (95% CI)Na% (95% CI)Na% (95% CI)
Median follow-up time until December 31, 2010∼17 y∼14 y∼10 y∼6 y∼2.5 y
III(c), Medulloblastoma27463 (57 to 68)27364 (58 to 70)28980 (74 to 85)24777 (72 to 83)17173 (67 to 79)
III(c)2, PNET7933 (23 to 44)6735 (23 to 46)6935 (23 to 47)4944 (30 to 58)2061 (44 to 78)
III(c)4, AT/RTb3421 (7 to 34)4228 (15 to 42)6142 (28 to 57)
IV(a), Neuroblastoma and ganglioneuroblastoma53163 (58 to 67)63779 (76 to 82)58976 (72 to 79)50777 (74 to 81)47380 (76 to 83)
 Neuroblastoma49861 (57 to 65)61579 (76 to 82)56375 (71 to 78)48276 (72 to 80)45879 (75 to 83)
 Ganglioneuroblastoma3385 (73 to 97)2291 (79 to 100)26100 (100 to 100)25100 (100 to 100)15100 (100 to 100)
V, Retinoblastoma16198 (96 to 100)16298 (96 to 100)17198 (95 to 100)151100 (100 to 100)10097 (94 to 100)
VI(a)1, Nephroblastoma (Wilms tumor)42589 (86 to 92)40592 (89 to 94)40694 (91 to 96)36093 (90 to 96)28394 (91 to 97)
VII (a), Hepatoblastoma5372 (60 to 84)5171 (58 to 83)5176 (65 to 88)7671 (61 to 81)4082 (72 to 91)
  • Estimated as in Brenner and Spix 2003.13 Follow-up until December 31, 2010. Dash indicates insufficient data.

  • a Cases with follow-up.

  • b For AT/RT, 2000–2010.